ConductScience.org, home

Cell line · CVCL_0125

4T1

Cancer cell line, Mus musculus. Malignant neoplasms of the mouse mammary gland. 261 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. 4T1. Cell lines, record CVCL_0125. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0125

On this page

Cell line

As Cellosaurus gives it.

Name
4T1
Accession
CVCL_0125
RRID
RRID:CVCL_0125
Synonyms
4T1-A, 4T1.0, 4T1/WT
Species
Mus musculus (Mouse)
Sex
Female
Age at sampling
Age unspecified
Category
Cancer cell line
Diseases
Malignant neoplasms of the mouse mammary gland (NCIt C21678)
Derived from
Mammary gland (in situ)
Parent
410.4 (CVCL_W343)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers261

PaperJournalYearHow we knowRetractedSource
Integrated Computational Pipeline Combining Metabolomics and Network Pharmacology for Bioactive Scaffold Discovery: Application to Antarctic Moss Chorisodontium aciphyllum.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Genetically engineered RNA inducers of proximity for protein regulation.Nat Commun2026Its Methods give the RRID and name the linePubMed
Nanocatalytic Immunotherapy Targeting Tumor-Resident Intracellular Bacteria for Triple-Negative Breast Cancer Treatment and Metastasis Suppression.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Ultrasound-Activated Ce(IV)-Integrated Biomimetic Nanoplatform for Oxygenation-Reinforced Gas-Sonodynamic Ferroptosis and cGAS-STING-Driven Antitumor Immunity.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Resistance to membrane damage enhances metastatic potential of breast cancer cells via dysregulated phospholipid profiles and annexin-mediated repair.Cell Mol Life Sci2026Its Methods give the RRID and name the linePubMed
A Multifunctional Metal-Based Nanomedicine for Copper Sequestration, in situ Toxification, and Immune Activation Against Metastatic Cancer.Int J Nanomedicine2026Its Methods give the RRID and name the linePubMed
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple-Negative Breast Cancer.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Synthesis and Biological Evaluation of a Lipophilic Vorinostat Prodrug.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
In Situ Gelling of TPZ-Loaded Nanogel for Sustained Intratumoral Delivery and Enhanced Cancer Immunotherapy.Gels2026Its Methods give the RRID and name the linePubMed

1 to 10 of 261

See all 261 papers

Relatives86

RelationCell lineAccessionProblemSource
Parent410.4CVCL_W343Cell lines
Derived from it4T1-Fluc-NeoCVCL_QZ57Cell lines
Derived from it4T1-Fluc-Neo/eGFP-PuroCVCL_QZ58Cell lines
Derived from it4T1-Fluc-Neo/iRFP-PuroCVCL_QZ59Cell lines
Derived from it4T1-Luc [JCRB]CVCL_J239Cell lines
Derived from it4T1-Luc [Ubigene]CVCL_C8UYCell lines
Derived from it4T1-Luc2 [ATCC]CVCL_A4BMCell lines
Derived from it4T1-Red-FLucCVCL_5I84Cell lines
Derived from it4T1-Red-FLuc-GFPCVCL_5I85Cell lines
Derived from it4T1-SCVCL_HE47Cell lines

Cell banks10

Cell bankCatalog numberStatusSource
ATCCCRL-2539ATCC
AddexBioC0006004/13Cellosaurus
BCRJ0022BCRJ
CCTCCGDC0294Cellosaurus
CLS300300CLS
EDITGENEEDC00063EDITGENE
HysigenTCM-C705Hysigen
KCBKCB 200967YJCellosaurus
NCBI_IranC604Cellosaurus
UbigeneYC-B004Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0125

GET https://conductscience.org/api/cell-lines/v1/CVCL_0125/papers?page=2